Heparin-Induced Thrombocytopenia (HIT)

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the typical onset time for HIT II?

  • 5-14 days after exposure to heparin (correct)
  • Within 24 hours of starting heparin
  • Within the first two days of heparin exposure
  • In the first 100 days after exposure to heparin

Which of the following is NOT a characteristic of HIT type I?

  • Typically occurs within the first two days of heparin exposure
  • Platelet count usually returns to normal with discontinued heparin administration
  • Has life-and limb-threatening thrombotic complications (correct)
  • A mild, transient drop in platelet count

What is the difference between HIT type I and HIT type II?

  • HIT type I is more common than HIT type II.
  • HIT type I is a direct effect of heparin on platelets, while HIT type II is an immune-mediated response. (correct)
  • HIT type I has life-threatening thrombotic complications, while HIT type II does not.
  • HIT type I is immune-mediated, while HIT type II is not.

What is the role of heparin-PF4-IgG complex in HIT?

<p>It is responsible for the immune-mediated response in HIT type II. (C)</p> Signup and view all the answers

Which of the following is a possible treatment for HIT?

<p>Administering a different type of anticoagulant (A)</p> Signup and view all the answers

What is 'Rapid-onset HIT'?

<p>HIT type II that occurs within 24 hours of starting heparin, in patients who have had heparin pre exposure within the last 100 days (B)</p> Signup and view all the answers

What is the relationship between heparin purity and the risk of HIT?

<p>Higher purity heparin is associated with a higher risk of HIT. (D)</p> Signup and view all the answers

Which of the following is a diagnostic test for HIT?

<p>Serology test (D)</p> Signup and view all the answers

What is the primary function of heparin in the context of blood clotting?

<p>To inhibit the conversion of fibrinogen into fibrin, preventing clot formation (C)</p> Signup and view all the answers

Heparin's mechanism of action involves the activation of which molecule?

<p>Antithrombin III (D)</p> Signup and view all the answers

Which of the following is NOT a potential side effect of heparin treatment?

<p>Elevated platelet count (A)</p> Signup and view all the answers

How does heparin become a procoagulant in the case of HIT?

<p>Heparin triggers the formation of antibodies that bind to platelets and activate them (C)</p> Signup and view all the answers

What is the primary concern regarding heparin use in patients with HIT?

<p>Development of further thrombotic events due to heparin's procoagulant effect (B)</p> Signup and view all the answers

Why is regular monitoring of platelet count crucial in patients receiving heparin therapy?

<p>To identify potential development of HIT and adjust treatment accordingly (A)</p> Signup and view all the answers

When is HIT suspected in a patient on heparin therapy?

<p>When there is a significant decrease in the platelet count, especially if exceeding 50% of the baseline (B)</p> Signup and view all the answers

What key factor differentiates heparin from other anticoagulants in terms of its administration?

<p>Heparin is typically administered intravenously, while others are oral (D)</p> Signup and view all the answers

What is the specific immune response involved in the pathogenesis of heparin-induced thrombocytopenia (HIT)?

<p>Production of immunoglobulin (Ig) G antibodies against the heparin-PF4 complex (B)</p> Signup and view all the answers

Which of the following clinical manifestations is MOST commonly associated with HIT?

<p>Deep venous thrombosis (DVT) (B)</p> Signup and view all the answers

How does heparin contribute to the development of HIT?

<p>Heparin enhances the binding of PF4 to platelets, increasing platelet activation. (A)</p> Signup and view all the answers

What is the specific role of the heparin-PF4 complex in the pathogenesis of HIT?

<p>It serves as an antigen that triggers the production of antibodies (D)</p> Signup and view all the answers

What is the significance of the 4T score in the diagnosis of HIT?

<p>It provides a clinical probability score for the presence of HIT (B)</p> Signup and view all the answers

What is the primary mechanism by which HIT leads to thrombocytopenia?

<p>Premature clearance of platelets by the spleen (D)</p> Signup and view all the answers

Which of the following diagnostic tests is the MOST definitive for the diagnosis of HIT?

<p>Serotonin Release Assay (D)</p> Signup and view all the answers

Which of the following statements regarding the timing of HIT development is TRUE?

<p>HIT can develop up to 3 weeks after heparin therapy has been discontinued (A)</p> Signup and view all the answers

Flashcards

Heparin

An anticoagulant that inhibits thrombin activity and prevents clot formation.

Antithrombin III

A protein that inactivates thrombin and factor Xa, thus inhibiting clotting.

Thrombin

An enzyme that converts fibrinogen to fibrin, crucial for clot formation.

Fibrinogen

A protein that is converted to fibrin by thrombin during blood clotting.

Signup and view all the flashcards

Heparin Induced Thrombocytopenia (HIT)

A complication of heparin causing decreased platelet count, leading to increased clotting risk.

Signup and view all the flashcards

Thrombocytopenia

A condition characterized by a low platelet count in the blood.

Signup and view all the flashcards

Pro-coagulant effect of heparin in HIT

In HIT, heparin acts to promote clotting instead of preventing it.

Signup and view all the flashcards

Monitoring Platelet Count with Heparin

Essential practice to detect potential HIT by observing changes in platelet levels.

Signup and view all the flashcards

Type I HIT

A transient, non-immune drop in platelet count occurring within 2 days of heparin exposure.

Signup and view all the flashcards

Type II HIT

An immune-mediated condition arising 5-14 days after heparin exposure with serious complications.

Signup and view all the flashcards

HIT diagnosis

Includes clinical scoring, platelet count analysis, and serological testing.

Signup and view all the flashcards

Serotonin release assay

A specific test to diagnose HIT by measuring serotonin release from platelets.

Signup and view all the flashcards

Alternative anticoagulant

A medication used in place of heparin when HIT is diagnosed.

Signup and view all the flashcards

Thrombosis

Formation of a blood clot within a blood vessel due to low platelet counts from HIT.

Signup and view all the flashcards

Platelet transfusion

A treatment option for patients with significant thrombocytopenia in HIT.

Signup and view all the flashcards

Delayed-onset HIT

Heparin-induced thrombocytopenia that occurs up to 3 weeks after heparin therapy stops.

Signup and view all the flashcards

Heparin-PF4 complex

A complex formed when heparin binds to platelet factor 4, triggering an immune response.

Signup and view all the flashcards

IgG antibodies

Immunoglobulin G antibodies produced in response to the heparin-PF4 complex.

Signup and view all the flashcards

Hypercoagulable state

A condition resulting in an increased tendency to form blood clots.

Signup and view all the flashcards

4T Score

A clinical scoring system used to assess the probability of heparin-induced thrombocytopenia.

Signup and view all the flashcards

Anti-PF4 test

An ELISA test that detects IgG antibodies against the PF4/heparin complex.

Signup and view all the flashcards

Study Notes

Heparin-Induced Thrombocytopenia (HIT)

  • HIT is a life-threatening complication of heparin exposure, occurring in patients regardless of dose, schedule, or administration route.
  • Heparin is administered as unfractionated heparin (UFH) or low molecular weight (LMWH) heparin.
  • HIT is more common with UFH than LMWH due to UFH's greater immunogenic property and greater cross-reactivity with PF4.

Types of HIT

  • HIT Type I (non-immune):

    • Mild, transient decrease in platelet count (typically within the first two days of heparin exposure).
    • Platelet count returns to normal with heparin discontinuation.
    • Direct non-immune-mediated platelet aggregation effect of heparin.
    • Not clinically significant.

  • HIT Type II (immune-mediated):

    • An immune-mediated disorder occurring 5-14 days after heparin exposure.
    • Characterized by potentially life-threatening thrombotic complications.
    • Three subtypes: Rapid-, Typical-, and Delayed-onset
      • Rapid-onset: Platelet count drop within 24 hours of starting heparin (pre-existing heparin exposure within the last 100 days)
      • Typical-onset: Onset 5-14 days after starting heparin
      • Delayed-onset: HIT symptoms develop up to three weeks after heparin discontinuation.

Pathophysiology of HIT

  • Heparin binds to platelet factor 4 (PF4), exposing a previously masked immune epitope.
  • This leads to the formation of a heparin-PF4 complex.
  • The complex triggers the production of immunoglobulin G (IgG) antibodies.
  • Antibodies bind to the heparin-PF4 complex, forming circulating immune complexes (CIC).
  • CICs bind to the Fc receptor on platelets, inducing platelet activation and aggregation resulting in thrombocytopenia and thrombosis.

Clinical Manifestations of HIT

  • Hypercoagulable state
  • Thrombocytopenia

Complications of HIT

  • Deep vein thrombosis (most frequent complication)
  • Pulmonary embolism (most frequent complication)
  • Myocardial infarction
  • Limb artery occlusion (potentially requiring amputation)
  • Transient ischemic attack (TIA)
  • Stroke
  • Skin necrosis
  • End-organ damage (e.g., adrenal, bowel, spleen, gallbladder, hepatic infarction, renal failure)
  • Death

Diagnosis of HIT

  • Clinical scoring (4T score) is used to assess the probability of HIT. Scores range from low, intermediate, to high probability.
  • Anti-PF4 antibody enzyme-linked immunosorbent assay (ELISA) test (detects IgG antibodies against the PF4/heparin complex but isn't specific).
  • Serotonin release assay (functional assay that measures heparin-dependent platelet activation—better predictor of thrombosis than anti-PF4 assay)

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Heparin Induced Thrombocytopenia (HIT) PDF

More Like This

Use Quizgecko on...
Browser
Open
Browser
Browser